Serofrecquancy of Human Immuno Deficiency virus among Known hepatitis Bvirus infected patients attending Talodihospital, SouthkordofanState, Sudan
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2015, Vol 4, Issue 2
Abstract
Background: Co infection with human immuno deficiency virus (HIV) and hepatitis B virus (HBV) is common; worldwide, an estimated 10% of HIV-infected persons have chronic hepatitis B; because The incidence of traditional acquired immunodeficiency syndrome Related opportunistic infections has decreased with successful anti-HIV therapy, liver disease has emerged as a leading cause of morbidity and mortality in HIV-infected individuals. This study aimed to detect serofrecquancy of Human Immuno Deficiency virus among known hepatitis B virus infected patients who attending Talodi hospital, South kordofan State, Sudan. Methods: This was descriptive cross sectional study included HBV infected patients aged between (11-54) years old with mean 30.4 years old conducted in Talodi hospital, South Kordofan, State, Sudan , During the period from November 2014 to January 2015 , 90 serum samples were tested by semi quantitative enzyme linked immune sorbent assay (ELISA) for the presence of anti HIV1, 2, 0 antibodies, and the relations between seropositivity and other factors, eg: age , gender, positive family history of blood transfusion, duration of having hepatitis B infection, surgery, blood transfusion, and cupping, were detected. Generated data were analyzed by using SPSS program. Result : Out of the total 90 patients who were HBsAg positive, attending Talodi hospital, South Kordofan, State, Sudan, were included in this study, 63(70%) were males, 27(30%)were females, out of them 29(32.2%), were positive for HIV. From them 21(23.3%) were males and 8(8.9%) were females. the seropositivity of HIV had associated with risk factors of gender, positive family history, cupping, surgery, and dental surgery. This study shown statistically in significant relationship between seropositivity of HIV and the above mentioned risk factors (p>0.05). Conclusion: the seropositivity of HIV among HBsAg is high in Talodi. Further confirmation and mentoring with large scale specimen is recommended.
Authors and Affiliations
Amal Ibrahim Elhag*| M.Sc Student Microbiology Department, Faculty of Medical Laboratory Sciences, Al Neelain University, Sudan., Wafa Ibrahim Elhag| Associate Professor- Microbiology Department, Faculty of Medical Laboratory Sciences, Al-Neelain University,sudan, Mokhtar Zakaria| Talodi hospital, Laboratory department, South Kordofan State, Sudan., Hamza Abdallh| Ministry of Health, Virology lab, Khartoum, State, Sudan
Expression of Her2/neu in Histological Sections of Sudanese Serous and Mucinous Ovarian Carcinoma
Background: HER2/neu over expression may be of some prognostic importance in advanced ovarian carcinoma; its role in early-stage disease has not been established. The current study examined the prevalence and significanc...
THE POSSIBLE PROPHYLACTIC EFFECT OF EGYPTIAN MORINGA OLEIFERA SEED OIL AS ANTI-ULCER ACTIVITY AND ANTI-INFLAMMATORY IN RATS.
Moringa oleifera Lam. is the multipurpose tree (therapeutic potential and nutritive value). In this work, authors focused on importance of Moringa oleifera seed oil (MSO) as antioxidant, anti-inflammatory and antiulcer....
EXTRACTION OF BIOACTIVE CHEMICAL COMPOUNDS AND ANTIBACTERIAL ACTIVITY OF BIOWASTE FRUIT PEELS EXTRACTS OF PUNICA GRANATUM
Recently, research has gained a renewed focus on herbal products and their biowaste that play an important role in the developing world due to limited modern health service. Various parts of Punica granatum was shown to...
PREVALENCEOF EXTENDED SPECTRUM β LACTAMASES (ESBL) IN NON-FERMENTING GRAM NEGATIVE BACILLI FROM CLINICAL ISOLATES.
Background and Objectives: Non fermenting gram negative bacilli (NFGNB) producing Extended spectrum β lactamases (ESBL) are an increasing cause of concern in the hospitals as they produce a therapeutic dilemma for the tr...
Pharmaceutical Packaging: Containers & Closures
Pharmaceutical packaging is regarded as an integral part of the end pharmaceutical product. The primary packaging is the one which is in direct contact with the product (i.e. bottle, cap, cap liner, label etc). The funct...